What is Cardiometabolic Disease Staging (CMDS)?
The Cardiometabolic Disease Staging (CMDS) system is a tool that you or your doctor can use to predict your risk of developing serious health conditions like heart disease and type 2 diabetes (4). It works by analyzing several important health factors, such as your weight, blood pressure, blood sugar levels, and cholesterol levels. These factors are combined to give a score that measures how likely you are to develop heart disease and/or diabetes in the future (i.e., over the next 10 years) (4). This score helps doctors identify individuals who are at high risk and might need to make lifestyle changes or receive medical treatment to prevent these diseases (4, 6). CMDS has been developed and validated in large cohort studies to be highly accurate. CMDS is the only tool that can accurately predict risk of both diabetes and heart disease (4).
How does the Cardiometabolic Disease Staging (CMDS) work?
If you are certain about the clinical information and lab results that need to be entered, you can use CMDS to calculate your score. It is preferable, but not required, for all lab results to have been obtained around the same time and within the last three years. This scoring system is particularly valuable because it doesn’t just look at one aspect of your health but takes a comprehensive view of how different risk factors associated with CMD interact (4). For example, even if your blood pressure is under control, other factors like your weight or blood sugar might still increase your overall risk. CMDS provides you with an overall numerical score of CMD severity, accompanied by your risk of future diabetes and CVD. It evaluates these factors collectively, rather than separately, to give a holistic picture of your health risks (4). The CMDS system helps your doctor focus on areas that need attention, aiming to prevent the onset of serious diseases through early intervention (4, 6). There is no more accurate way to predict future risk of diabetes, and CMDS is as good or better than other ways to predict cardiovascular disease risk (4). See Section "About Cardiometabolic Disease" to learn more about cardiometabolic disease.
